| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.16 | 0.003 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.097 | 0.004 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.005 |